Pacific health researchers are starting clinical trials in early 2024 to explore kava as an alternate treatment for post-traumatic stress disorder (PTSD).
See the latest developments from the health and nutrition brands across Asia-Pacific, including Herbs of Gold’s plan to debut in Vietnam via mum-and-baby chain, Japan’s Shinryo to relaunch hydrogen-rich jelly sleep supplement, and Taiwanese brand Jerôsse's...
Changing the labelling requirements on kava would place “unreasonable and unnecessary” burden on companies, but authorities could do with post-market surveillance, Fiji Kava said in response to the ongoing regulatory debate on kava in the Oceania.